| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/17/2003 | EP1370297A2 Method and composition |
| 12/17/2003 | EP1370292A1 Use of cd23 antagonists for the treatment of neoplastic disorders |
| 12/17/2003 | EP1370290A2 Molecular antigen array |
| 12/17/2003 | EP1370289A2 Method for producing a vaccine containing autologous antibodies |
| 12/17/2003 | EP1370288A2 Method for treating thrombocytopenia with monoclonal ivig |
| 12/17/2003 | EP1370286A1 Compositions of multimeric profilin for diagnosis and treatment of allergies |
| 12/17/2003 | EP1370285A2 A vaccine composition and method of using the same |
| 12/17/2003 | EP1370284A2 Bacteriophage-mediated immunisation |
| 12/17/2003 | EP1370283A2 Prevention of recurrent viral disease |
| 12/17/2003 | EP1370275A2 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside |
| 12/17/2003 | EP1163024B1 Delivery of macromolecules into cells |
| 12/17/2003 | EP1066043B1 Materials for the treatment of conditions involving mast cells, basophils and eosinophils |
| 12/17/2003 | EP1028715B1 Dosage composition for nasal delivery comprising vibrio cholera zonula occludens toxin as absorption enhancer |
| 12/17/2003 | EP0956349B1 Synthetic hpv16 virus-like particles |
| 12/17/2003 | EP0936923B1 SUPPRESSION OF TNFalpha AND IL-12 IN THERAPY |
| 12/17/2003 | EP0852490B1 Emulsion formulations for the delivery of nucleic acids to cells |
| 12/17/2003 | EP0669984B1 Actinobacillus pleuropneumoniae outer membrane lipoprotein a and uses thereof |
| 12/17/2003 | EP0571387B1 A non-mitogenic competitive hgf antagonist |
| 12/17/2003 | EP0552142B2 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 12/17/2003 | EP0536352B1 Therapeutic and preventive vaccines for hiv |
| 12/17/2003 | EP0527753B2 Purification and use of pertactin, a bordetella pertussis outer membrane protein |
| 12/17/2003 | EP0424437B1 Recombinant mycobacterial expression vehicles and uses therefor |
| 12/17/2003 | CN1462309A Codon-optimized papilloma virus sequences |
| 12/17/2003 | CN1462192A Blood cell production via activation of hemeglobin scavenger receptor |
| 12/17/2003 | CN1462190A The use of copolymer 1 and related peptides and polypeptides and T cell treated therewith for neuroprotective therapy |
| 12/17/2003 | CN1131314C Recombination eukaryotic carrier containing sensitinogen gene and application thereof |
| 12/16/2003 | US6664385 Kidney injury-related molecules |
| 12/16/2003 | US6664378 Use of kits containing an antibody binding a specific urogenital carcinoma tumor liberated protein (TLP) epitope for identifying TLP and for diagnosing urogenital carcinoma. |
| 12/16/2003 | US6664377 Use of polypeptides comprising a portion of a prostate tumor protein and to polynucleotide molecules encoding such poly-peptides and kits containing vaccines and pharmaceutical compositions for treatment of prostate cancer |
| 12/16/2003 | US6664370 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 12/16/2003 | US6664229 Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72 |
| 12/16/2003 | US6664227 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
| 12/16/2003 | US6664105 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells |
| 12/16/2003 | US6664099 Method for the preservation of viruses and mycoplasma |
| 12/16/2003 | US6664096 Nutrient broths for use in the propagation of microorganism |
| 12/16/2003 | US6664094 Use of mutants of Neisseria gonorrhoeae in vaccine production which contain mutations in a major outer membrane protein gene such that no immunologically functional polypeptides encoded by said gene are produced |
| 12/16/2003 | US6664090 Carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 12/16/2003 | US6664066 Modified Morbillivirus V proteins |
| 12/16/2003 | US6664050 Assaying a sample using an antibody specific to an adenovirus type 36p to test for the presence of the adenovirus; thus testing whether the person has been or is infected with adenovirus type 36p |
| 12/16/2003 | US6664041 Method for preparing a viral extract containing HIV-II RNA |
| 12/16/2003 | US6663879 Injectable compositions |
| 12/16/2003 | US6663873 Antigenic preparation for treatment or prevention of helicobacter infection |
| 12/16/2003 | US6663872 Immune response |
| 12/16/2003 | US6663871 Non-replicating or replication- impaired pox virus vector carrying at least one CD8 T cell epitope which is also present in the priming composition, malaria |
| 12/16/2003 | US6663869 Linkages between polypeptide organic molecules are oxime linkages formed by reaction of a keto, aldehyde or amino-oxy group on the amino acid |
| 12/16/2003 | US6663868 Heat shock protein-based vaccines and immunotherapies |
| 12/16/2003 | US6663865 Tumor necrosis factor antagonists and their use in endometriosis |
| 12/16/2003 | US6663863 Method of inhibiting stenosis and restenosis |
| 12/16/2003 | CA2286879C Novel method for the production of anti-human antigen receptors and uses thereof |
| 12/16/2003 | CA2134751C Monoclonal antibodies and their use |
| 12/16/2003 | CA2072627C Recombinant herpes simplex viruses vaccines and methods |
| 12/14/2003 | CA2432496A1 Diagnostic and therapeutic uses of sufu gene |
| 12/14/2003 | CA2430259A1 Vaccine |
| 12/11/2003 | WO2003102219A2 Improved pseudotyped retroviruses |
| 12/11/2003 | WO2003102207A2 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 12/11/2003 | WO2003102191A1 Immunogenic sequences |
| 12/11/2003 | WO2003102189A1 Allergen from mugwort pollen |
| 12/11/2003 | WO2003102187A1 Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence |
| 12/11/2003 | WO2003102168A1 Attenuated listeria spp. and methods for using the same |
| 12/11/2003 | WO2003102166A2 Novel flavivirus antigens |
| 12/11/2003 | WO2003102165A2 IMMUNOGENIC HBc CHIMER PARTICLES STABILIZED WITH AN N-TERMINAL CYSTEINE |
| 12/11/2003 | WO2003102164A2 Cancer-linked gene as target for chemotherapy |
| 12/11/2003 | WO2003102163A2 Methods of diagnosing and treating diabetes and insulin resistance |
| 12/11/2003 | WO2003102153A2 Cell migration inhibiting compositions and methods and compositions for treating cancer |
| 12/11/2003 | WO2003102144A2 Compositions and methods of use for an ephrin rreceptor |
| 12/11/2003 | WO2003102028A1 Rb1 gene induced protein (rb1cc1) and gene |
| 12/11/2003 | WO2003102025A1 Protein inducing cell death of helicobacter pylori |
| 12/11/2003 | WO2003102021A2 Cotton rat lung cells for virus culture |
| 12/11/2003 | WO2003101495A1 Methods and compositions for radioimmunotherapy of brain and cns tumors |
| 12/11/2003 | WO2003101485A1 Cd16a binding proteins and use for the treatment of immune disorders |
| 12/11/2003 | WO2003101484A1 Compositions and methods for transepithelial molecular transport |
| 12/11/2003 | WO2003101482A2 Liposome vaccine formulations for fin-fish |
| 12/11/2003 | WO2003101463A1 Method and agent for the prevention, inhibition and treatment of sepsis |
| 12/11/2003 | WO2003101399A2 Novel bacterium for treatment of disease |
| 12/11/2003 | WO2003101397A2 Tetravalent dengue vaccines |
| 12/11/2003 | WO2003101396A2 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 12/11/2003 | WO2003101375A2 Immunostimulatory oligonucleotides and uses thereof |
| 12/11/2003 | WO2003101283A2 Diagnostics markers for lung cancer |
| 12/11/2003 | WO2003101173A2 Immunomodulatory constructs and their uses |
| 12/11/2003 | WO2003074568A9 Individualized anti-cancer antibodies |
| 12/11/2003 | WO2003066079A3 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds |
| 12/11/2003 | WO2003063772A3 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies |
| 12/11/2003 | WO2003054212A3 A method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral dna |
| 12/11/2003 | WO2003052076A3 Identification of essential genes of cryptococcus neoformans and methods of use |
| 12/11/2003 | WO2003051180A3 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832 |
| 12/11/2003 | WO2003048348A3 Production of viruses, viral isolates and vaccines |
| 12/11/2003 | WO2003048304A3 ALLOIOCOCCUS OTITIDIS OPEN READING FRAMES (ORFs) ENCODING POLYPEPTIDE ANTIGENS, IMMUNOGENIC COMPOSITIONS AND USES THEREOF |
| 12/11/2003 | WO2003048206A3 Growth hormone agonist peptides and their uses |
| 12/11/2003 | WO2003044048A3 Methylated heparin-binding hemagglutinin (hbha) recombinant mycobacterial antigen |
| 12/11/2003 | WO2003035104A3 Compositions and methods for selected tumor treatment |
| 12/11/2003 | WO2003026579A3 Combination therapies for immune mediated diseases |
| 12/11/2003 | WO2003025012A3 Therapeutic vaccine peptide complex for preventing and treating disorders in mammals |
| 12/11/2003 | WO2003023042A9 Recombinant mva capable of expressing structural hcv antigens |
| 12/11/2003 | WO2003017940A3 Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption |
| 12/11/2003 | WO2003017933A3 Method and apparatus using idstm for multi-agent therapy |
| 12/11/2003 | WO2003003975A3 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 12/11/2003 | WO2003002745A3 The cage gene of actinobacillus actinomycetemcomitans, the protein it encodes and uses thereof |
| 12/11/2003 | WO2003002142A8 Cancer vaccine containing cancer antigen based on tumor suppressor gene wt1 product and cationic liposomes |
| 12/11/2003 | WO2003000727A3 Atopy |
| 12/11/2003 | WO2002102324A3 Anti-arthropod vector vaccines methods of selecting and uses thereof |